NCT02425501View on ClinicalTrials.gov

Special Drug Use Investigation of EYLEA for Diabetic Macular Edema

CompletedOBSERVATIONAL

Enrollment

646

Participants

Timeline

Start Date

January 20, 2015

Primary Completion Date

April 26, 2019

Study Completion Date

August 13, 2019

Conditions

Macular Edema

Interventions

DRUG

Aflibercept (Eylea, BAY86-5321)

Administration by intravitreal injection

Trial Locations (1)

Unknown

Multiple Locations

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Bayer

INDUSTRY